Armata Pharmaceuticals (ARMP) Restructuring Costs (2014 - 2026)

Armata Pharmaceuticals has disclosed Restructuring Costs across 5 years of filings, most recently posting $2.2 million for Q2 2026.

• In Q2 2026, Restructuring Costs rose 53.43% year-over-year to $2.2 million; the TTM figure through Jun 2026 stood at $8.4 million (up 13.58% YoY), while the FY2025 annual figure was $7.5 million, down 8.93% from the prior year.
• Restructuring Costs came in at $2.2 million for Q2 2026 at Armata Pharmaceuticals, up from $2.0 million in the prior quarter.
• In the past five years, Restructuring Costs ranged from a high of $2.3 million in Q4 2025 to a low of $1.4 million in Q2 2025.
• Average Restructuring Costs over 3 years is $2.0 million, with a median of $2.0 million recorded in 2024.
• Year-over-year, Restructuring Costs dropped 23.55% in 2025 and surged 53.43% in 2026.
• Over 3 years, Restructuring Costs stood at $2.2 million in 2024, then grew by 4.43% to $2.3 million in 2025, then declined by 3.14% to $2.2 million in 2026.
• Per Business Quant data, the three most recent Restructuring Costs figures were $2.2 million in Q2 2026, $2.0 million in Q1 2026, and $2.3 million in Q4 2025.